Daten
Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2023-2024
Lehrbeauftragte/r
-
Dr. Kinga HADZSIEV
assistant professor,
Department of Medical Genetics -
Semesterwochenstunden
Vorlesungen: 12
Praktika: 0
Seminare: 0
Insgesamt: 12
Fachangaben
- Kode des Kurses: OAF-EST-T
- 1 kredit
- General Medicine
- Optional modul
- autumn
OAA-HUG-T completed
Zahl der Kursteilnehmer für den Kurs:
min. 5 – max. 20
Erreichbar als Campus-Kurs für 20 fő számára. Campus-karok: ÁOK
Thematik
Rare diseases, while individually each disease is rare, collectively are common. More than 10,000 rare diseases affect nearly 400 million people worldwide. The personal and economic burdens of rare diseases are immense. Most of the rare diseases are caused by defective genes that impair quality of life and can lead to premature death. Gene therapy is a logical way to treat rare genetic diseases; cure a single gene defect by introducing a 'correct' gene. Today, there are only a handful therapies for rare diseases. As gene and other high-definition therapies are still under development, it is still unclear whether they will be successful in treating these diseases. In this course, we aim to address the potential and challenges of high-definition therapies for the treatment of rare genetic diseases.
Vorlesungen
- 1. Introduction to rare genetic disorders - Dr. Morava-Kozicz Éva
- 2. Introduction to rare genetic disorders - Dr. Morava-Kozicz Éva
- 3. Introduction to genetic therapies - Dr. Hadzsiev Kinga
- 4. Introduction to genetic therapies - Dr. Hadzsiev Kinga
- 5. The utility of induced pluripotent stem cell (iPSC) derived models in mitochondrial disease - Dr. Kozicz László Tamás
- 6. The utility of induced pluripotent stem cell (iPSC) derived models in mitochondrial disease - Dr. Kozicz László Tamás
- 7. Drug repurposing in congenital disorders of glycosylation - Dr. Morava-Kozicz Éva
- 8. Drug repurposing in congenital disorders of glycosylation - Dr. Morava-Kozicz Éva
- 9. Gene therapy in cardiomyopathy - Dr. Kozicz László Tamás
- 10. Gene therapy in cardiomyopathy - Dr. Kozicz László Tamás
- 11. Novel therapeutic approaches in rare disorders; liposomal targeting, mRNA treatment, ASO etc. - Dr. Morava-Kozicz Éva
- 12. Novel therapeutic approaches in rare disorders; liposomal targeting, mRNA treatment, ASO etc. - Dr. Morava-Kozicz Éva
Praktika
Seminare
Materialien zum Aneignen des Lehrstoffes
Obligatorische Literatur
Vom Institut veröffentlichter Lehrstoff
Az előadások anyagai.
Skript
Empfohlene Literatur
Voraussetzung zum Absolvieren des Semesters
Maximum of 15 % absence allowed
Semesteranforderungen
Beszámoló vagy vizsga
Möglichkeiten zur Nachholung der Fehlzeiten
Nincs lehetőség pótlásra.
Prüfungsfragen
Neptun Meet Street